Valuation: Zentiva,

Market Cap 243M 212M 200M 182M 340M 23.32B 342M 2.4B 925M 11.86B 913M 893M 38.15B P/E 2017
7.27x
P/E 2018 177x
Enterprise Value 242M 211M 199M 181M 339M 23.25B 341M 2.39B 922M 11.82B 910M 890M 38.03B EV / Sales 2017
3.97x
EV / Sales 2018 11.2x
Free-Float
4.05%
Yield 2017
13.8%
Yield 2018 -
6 months+3.33%
Current year+3.33%
Current year 29
Extreme 29
33
1 year 29
Extreme 29
45
3 years 24
Extreme 24
45
5 years 24
Extreme 24
45
10 years 11
Extreme 11
370
Manager TitleAgeSince
Chief Executive Officer - 11/11/2015
Corporate Officer/Principal - 17/08/2022
Director TitleAgeSince
Director/Board Member - 07/07/2013
Director/Board Member - 17/10/2018
Director/Board Member 58 14/11/2020
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-31.11%+3.33% 57.6M
-1.61%-0.15%+10.95%+60.09% 45.94B
-1.02%-1.90%+36.59%+99.64% 37.22B
+2.19%+3.65%+11.83%+80.29% 12.06B
+1.32%+2.09%-11.51%+12.41% 11.74B
-0.95%0.00%+19.27%+141.86% 9.03B
+0.39%+2.39%+31.05%+39.38% 7.36B
-0.06%+2.97%+39.67%-18.37% 7.15B
+1.30%+1.17%+17.37%+187.41% 7.2B
+0.70%+1.10%-41.96%+5.34% 5.03B
Average +0.23%+0.98%+8.21%+61.14% 14.28B
Weighted average by Cap. -0.44%+0.23%+17.31%+72.83%

Financials

2017 2018
Net sales 143M 124M 117M 107M 200M 13.69B 201M 1.41B 543M 6.96B 536M 524M 22.4B 36.17M 31.54M 29.78M 27.05M 50.67M 3.47B 50.89M 357M 138M 1.76B 136M 133M 5.68B
Net income 77.98M 68M 64.2M 58.3M 109M 7.48B 110M 769M 297M 3.8B 293M 286M 12.24B 2.29M 2M 1.89M 1.71M 3.21M 220M 3.22M 22.59M 8.72M 112M 8.6M 8.41M 359M
Net Debt -0.09 -0.08 -0.08 -0.07 -0.13 -8.83 -0.13 -0.91 -0.35 -4.49 -0.35 -0.34 -14.44 -0.77 -0.67 -0.64 -0.58 -1.08 -74.27 -1.09 -7.63 -2.95 -37.76 -2.91 -2.84 -121.5
Logo Zentiva,
Zentiva as is a Slovakia-based company engaged in generic pharmaceuticals business sector. The Company develops, manufactures, and sells generic medicinal products, primarily used in primary care sector. Its portfolio includes preparations for various therapeutic areas, including cardiovascular system, women’s healthcare, respiratory system, antimicrobials, urological system, central nervous system, pain, and gastrointestinal system.
Employees
90
  1. Stock Market
  2. Stocks
  3. 1SKF401E Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!